1
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Al-Sohaily S, Biankin A, Leong R,
Kohonen-Corish M and Warusavitarne J: Molecular pathways in
colorectal cancer. J Gastroenterol Hepatol. 27:1423–1431. 2012.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Stracci F, Zorzi M and Grazzini G:
Colorectal cancer screening: tests, strategies, and perspectives.
Front Public Health. 2:2102014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Benton SC, Seaman HE and Halloran SP:
Faecal occult blood testing for colorectal cancer screening: The
past or the future. Curr Gastroenterol Rep. 17:4282015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Wallace MB and Kiesslich R: Advances in
endoscopic imaging of colorectal neoplasia. Gastroenterology.
138:2140–2150. 2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Puylaert JB, van der Zant FM and Rijke AM:
Sonography and the acute abdomen: Practical considerations. AJR Am
J Roentgenol. 168:179–186. 1997. View Article : Google Scholar : PubMed/NCBI
|
7
|
Laméris W, van Randen A, Dijkgraaf MG,
Bossuyt PM, Stoker J and Boermeester MA: Optimization of diagnostic
imaging use in patients with acute abdominal pain (OPTIMA): Design
and rationale. BMC Emerg Med. 7:92007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Dhillon S, Halligan S, Goh V, Matravers P,
Chambers A and Remedios D: The therapeutic impact of abdominal
ultrasound in patients with acute abdominal symptoms. Clin Radiol.
57:268–271. 2002. View Article : Google Scholar : PubMed/NCBI
|
9
|
Tomizawa M, Shinozaki F, Sugiyama T,
Yamamoto S, Sueishi M and Yoshida T: Ultrasonography for
leukocytosis or elevated C-reactive protein.
Hepatogastroenterology. 58:1156–1158. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Shirahama M, Koga T, Ishibashi H, Uchida S
and Ohta Y: Sonographic features of colon carcinoma seen with
high-frequency transabdominal ultrasound. J Clin Ultrasound.
22:359–365. 1994. View Article : Google Scholar : PubMed/NCBI
|
11
|
Tomizawa M, Shinozaki F, Hasegawa R, Fugo
K, Shirai Y, Ichiki N, Sugiyama T, Yamamoto S, Sueishi M and
Yoshida T: Screening ultrasonography is useful for the diagnosis of
gastric and colorectal cancer. Hepatogastroenterology. 60:517–521.
2013.PubMed/NCBI
|
12
|
Truong M, Atri M, Bret PM, Reinhold C,
Kintzen G, Thibodeau M, Aldis AE and Chang Y: Sonographic
appearance of benign and malignant conditions of the colon. AJR Am
J Roentgenol. 170:1451–1455. 1998. View Article : Google Scholar : PubMed/NCBI
|
13
|
O'Malley ME and Wilson SR: US of
gastrointestinal tract abnormalities with CT correlation.
Radiographics. 23:59–72. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Fisher JK: Normal colon wall thickness on
CT. Radiology. 145:415–418. 1982. View Article : Google Scholar : PubMed/NCBI
|
15
|
Stermer E, Lavy A, Rainis T, Goldstein O,
Keren D and Zeina AR: Incidental colorectal computed tomography
abnormalities: Would you send every patient for a colonoscopy? Can
J Gastroenterol. 22:758–760. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Choi SJ, Kim HS, Ahn SJ, Jeong YM and Choi
HY: Evaluation of the growth pattern of carcinoma of colon and
rectum by MDCT. Acta Radiol. 54:487–492. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Heo SH, Kim JW, Shin SS, Jeong YY and Kang
HK: Multimodal imaging evaluation in staging of rectal cancer.
World J Gastroenterol. 20:4244–4255. 2014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Xu D, Ju HX, Qian CW and Jiang F: The
value of TRUS in the staging of rectal carcinoma before and after
radiotherapy and comparison with the staging postoperative
pathology. Clin Radiol. 69:481–484. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Tomizawa M, Shinozaki F, Hasegawa R,
Togawa A, Shirai Y, Ichiki N, Motoyoshi Y, Sugiyama T, Yamamoto S
and Sueishi M: Reduced hemoglobin and increased C-reactive protein
are associated with upper gastrointestinal bleeding. World J
Gastroenterol. 20:1311–1317. 2014. View Article : Google Scholar : PubMed/NCBI
|
20
|
Shibutani M, Maeda K, Nagahara H, Ohtani
H, Sugano K, Ikeya T, Kimura K, Amano R, Kubo N, Tanaka H, et al:
Elevated preoperative serum C-reactive protein levels are
associated with poor survival in patients with colorectal cancer.
Hepatogastroenterology. 61:2236–2240. 2014.PubMed/NCBI
|
21
|
Khanbhai M, Shah M, Cantanhede G, Ilyas S
and Richards T: The problem of anaemia in patients with colorectal
cancer. ISRN Hematol. 2014:5479142014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Stiksma J, Grootendorst DC and van der
Linden PW: CA 19-9 as a marker in addition to CEA to monitor
colorectal cancer. Clin Colorectal Cancer. 13:239–244. 2014.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Li Destri G, Rubino AS, Latino R, Giannone
F, Lanteri R, Scilletta B and Di Cataldo A: Preoperative
carcinoembryonic antigen and prognosis of colorectal cancer. An
independent prognostic factor still reliable. Int Surg.
100:617–625. 2015. View Article : Google Scholar : PubMed/NCBI
|